Accuray receives Nasdaq deficiency notice for bid price below $1; 180-day cure period

ACCURAY INC

Received Nasdaq notice on Feb 2, 2026 for non-compliance with $1 minimum bid price rule.
Has 180-day compliance period until Aug 3, 2026 to regain compliance by closing bid >= $1 for 10 consecutive days.
May be eligible for second 180-day period by transferring to Nasdaq Capital Market if not cured initially.
Common stock continues trading under symbol ARAY while company evaluates options.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.